About DYNAVAX TECHNOLOGIES CORPORATION
Dynavax Technologies is a commercial-stage biopharmaceutical company focused on developing and commercializing novel vaccines to protect against infectious diseases using proven adjuvant technology. The company has a management team with extensive experience in drug development and commercialization, including experience with government organizations.
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| MCKESSON CONTROLLED 9-5-25 | Department of Justice | $364 |
Is this your company?
Claim DYNAVAX TECHNOLOGIES CORPORATION to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim DYNAVAX TECHNOLOGIES CORPORATION & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.